Randomized Controlled Trials
GPTKB entity
Statements (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
scientific study design
|
gptkbp:aimsTo |
reduce bias
establish causality |
gptkbp:alsoKnownAs |
gptkb:RCTs
|
gptkbp:analyzes |
intention-to-treat analysis
per-protocol analysis |
gptkbp:canBe |
safety
effectiveness crossover pragmatic treatments double-blind adaptive efficacy preventive measures open-label interventions cluster-randomized parallel-group single-blind triple-blind |
gptkbp:considers |
gold standard in clinical trials
|
gptkbp:contrastsWith |
observational studies
cohort studies case-control studies |
gptkbp:feature |
blinding
control group placebo experimental group random allocation |
https://www.w3.org/2000/01/rdf-schema#label |
Randomized Controlled Trials
|
gptkbp:introducedIn |
1940s
|
gptkbp:inventedBy |
gptkb:Austin_Bradford_Hill
|
gptkbp:outcomeMeasuredBy |
primary outcome
secondary outcome |
gptkbp:registeredIn |
gptkb:ISRCTN_registry
gptkb:ClinicalTrials.gov |
gptkbp:regulates |
gptkb:FDA
gptkb:EMA |
gptkbp:reportsTo |
gptkb:CONSORT_guidelines
|
gptkbp:requires |
informed consent
ethical approval randomization allocation concealment |
gptkbp:riskOfBias |
selection bias
attrition bias detection bias performance bias reporting bias |
gptkbp:usedIn |
education research
social sciences clinical research psychology research |
gptkbp:bfsParent |
gptkb:Causal_Relations
gptkb:Causal_Analysis |
gptkbp:bfsLayer |
6
|